Bowling Portfolio Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Bowling Portfolio Management’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-166,088	Closed	-$2.98M	–	438
2017 Q4	$2.98M	Buy	166,088 +45,035	+37%	+$554K	0.4%	77
2017 Q3	$1.43M	Sell	121,053 -13,968	-10%	-$157K	0.21%	158
2017 Q2	$1.42M	Buy	135,021 +86,750	+180%	+$884K	0.21%	142
2017 Q1	$531K	Buy	+48,271	New	+$560K	0.09%	263

Other funds holding SCMP

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Bowling Portfolio Management's SCMP Position: Q1 2018 in Review

Bowling Portfolio Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 166,088 shares — an estimated $2.98M sold.

Bowling Portfolio Management first reported a position in SCMP in Q1 2017 and held it in 4 quarters. The position peaked at $2.98M in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

Bowling Portfolio Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
Bowling Portfolio Management sold 166,088 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $2.98M.
Bowling Portfolio Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q1 2017 and held it in 4 quarters.
Bowling Portfolio Management's Sucampo Pharmaceuticals, Inc. position peaked at $2.98M in Q4 2017.
3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Bowling Portfolio Management's 13F filing for Q1 2018, filed 25 Apr 2018.